Navigation Links
Life Extension® Announces Recruitment for Alzheimer's Clinical Trial in South Florida
Date:8/25/2011

FT. LAUDERDALE, Fla., Aug. 25, 2011 /PRNewswire/ -- Life Extension, a pioneer in the latest anti-aging research and integrative health therapies, while offering superior quality, research-backed dietary supplements, is actively recruiting participants for a free clinical trial to study the effects of natural supplements and an innovative medical therapy on Alzheimer's disease. Mild to moderate Alzheimer's patients (as diagnosed by their physician) are needed for a 17- to 18-week study. This study requires weekly visits to the office of the study's principal investigator located in the Fort Lauderdale area. Participants will receive blood tests, medical evaluations, blood pressure checks, and study medication and supplements at no cost.

The objective of Life Extension's new clinical trial is to measure the effects of weekly injections of Enbrel® (generic name etanercept), a commonly used medication for autoimmune disorders such as rheumatoid arthritis, and nutritional supplements that may help suppress the inflammatory factor implicated in the neuronal degeneration of Alzheimer's disease. Twenty million Americans today are destined to contract Alzheimer's disease, an affliction that robs memory, intelligence and eventually the most rudimentary cognitive abilities. The few medications currently approved to treat Alzheimer's symptoms produce only modest, short-term effects. Some patients cannot tolerate them at all.

Dr. Steven Hirsch, Director of Clinical Research at Life Extension, stated that "Up until now, a diagnosis of Alzheimer's disease meant one was destined to slowly be deprived of all cognitive function, a condition that tops the list of aging people's disease fears. This is the first clinical trial sponsored by Life Extension that will permit us to better understand Alzheimer's disease and how traditional medications, in conjunction with nutritional supplements, may affect its progress. We are seeking volunteers who meet the criteria for inclusion into the study in order to help future patients diagnosed with the disease."

To participate in this study register online or send an e-mail expressing your interest in participating in this study to: LEClinicalResearch@LifeExtension.com. For further information you may also call the Life Extension Clinical Research Department at (866) 517-4536.

About Life Extension

For more than 30 years, Life Extension has been a pioneer in funding and reporting the latest anti-aging research and integrative health therapies while offering superior-quality dietary supplements to consumers.  A trailblazer in the $26 billion U.S. dietary supplements industry, Life Extension's core mission is to extend the healthy human life span using an integrative approach and funding cutting-edge scientific research. For more information, visit www.lef.org, www.Twitter.com/LifeExtension, www.Facebook.com/LifeExtension and www.YouTube.com/LifeExtensionVideos.

Contact:
Jennifer Noel
RF|Binder for Life Extension
212-994-7502
Jennifer.noel@rfbinder.com


'/>"/>
SOURCE Life Extension
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Life Extension® Launches New Product Containing ChromaDexs pTeroPure® Pterostilbene
2. PDI Announces Renewal of Engagement for 7th Consecutive Season
3. Nutrastar Announces Adoption of Share Repurchase Program
4. ePharmaSolutions Announces the Deployment of its Enterprise Clinical Trial Portal for Two Global Biopharmaceutical Companies
5. CVS Caremark Corporation Announces New Share Repurchase Authorization for up to $4 Billion of Common Stock
6. ChemOutsourcing Announces the 62 Exhibitors to Present API & New Chemical Technologies at September 12-15, 2011 Show in NJ
7. VIVUS Announces $45.8 Million Registered Direct Offering of Common Stock
8. Concord Medical Services Holdings Announces Participation in Coming Investor Conferences
9. Avant Healthcare Marketing Announces West Coast Expansion
10. Elbit Imaging Ltd. Announces Interest Rate for the Next Interest Period for Series B Notes
11. China Nepstar Chain Drugstore Announces Share Repurchase Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... Calif. , Feb. 4, 2016  Edwards Lifesciences ... patient-focused innovations for structural heart disease and critical care ... accelerated share repurchase (ASR) agreement with Morgan Stanley & ... stock.  This repurchase is part of the Company,s previously ... the Company,s common stock.  --> ...
(Date:2/4/2016)... Feb. 4, 2016 Worldwide Radiology Oncology ... growth as next generation systems provide a way ... for cancer surgery. New systems pinpoint the delivery ... has been such a problem previously, limiting the ... robots take cancer surgery far beyond what has ...
(Date:2/4/2016)... Calif. , Feb. 4, 2016  SciClone ... today announced it has entered into a settlement ... Commission (SEC) fully resolving the SEC,s investigation into ... (FCPA).  Under the terms of the settlement agreement, ... $12.8 million, including disgorgement, pre-judgment interest and a ...
Breaking Medicine Technology:
(Date:2/5/2016)... ... February 05, 2016 , ... Freed-Hardeman University President Joe ... signed a joint enrollment and degree completion agreement. The agreement, which begins ... degrees at FHU|Dickson. , The agreement allows students to be jointly admitted ...
(Date:2/5/2016)... ... February 05, 2016 , ... In the fourth ... country gathered at the La Valencia Hotel in San Diego, California to discuss ... named the year’s most outstanding franchise, walking away with the coveted David Wright ...
(Date:2/5/2016)... SARASOTA, Fla., (PRWEB) , ... February 05, 2016 , ... ... appetizing recipes just in time for this weekend’s Big Game. Take the stress out ... ingredients that will keep your guests happy at every stage of the game. , ...
(Date:2/5/2016)... ... February 05, 2016 , ... Stuart Bentkover, MD, FACS is ... to provide the most effective tattoo removal today, Dr. Bentkover is the only doctor ... by Cynosure, the PicoSure has been approved by the Food and Drug Administration (FDA) ...
(Date:2/5/2016)... ... February 05, 2016 , ... Health and wellness is a topic that should ... event they are experiencing an illness. Migraines are a severe form of a headache ... migraines would not wish the pain on their worst enemy, the feeling can last ...
Breaking Medicine News(10 mins):